Cairn Investment Group’s AbbVie ABBV Stock Holding History

Cairn Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Hold	973	–	–	0.11%	65
2026 Q1	$212K	Hold	973	–	–	0.11%	63
2025 Q4	$222K	Hold	973	–	–	0.11%	65
2025 Q3	$225K	Buy	+973	New	+$198K	0.1%	69
2023 Q1	–	Sell	-2,482	Closed	-$401K	–	65
2022 Q4	$401K	Buy	2,482 +346	+16%	+$53.1K	0.3%	52
2022 Q3	$287K	Sell	2,136 -259	-11%	-$37.2K	0.23%	60
2022 Q2	$367K	Buy	+2,395	New	+$366K	0.29%	60

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cairn Investment Group's ABBV Position: Q2 2026 in Review

Cairn Investment Group held its AbbVie (ABBV) position steady in Q2 2026 at 973 shares worth $245K. The position accounts for 0.11% of the portfolio, ranked #65.

Cairn Investment Group first reported a position in ABBV in Q2 2022 and has held it in 7 quarters since. The position peaked at $401K in Q4 2022. 4,219 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cairn Investment Group held 973 shares of AbbVie worth $245K as of Q2 2026.
Cairn Investment Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.11% of Cairn Investment Group's portfolio in Q2 2026, its #65 holding.
Cairn Investment Group first reported a position in AbbVie in Q2 2022 and has held it in 7 quarters since.
Cairn Investment Group's AbbVie position peaked at $401K in Q4 2022.
4,219 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cairn Investment Group's 13F filing for Q2 2026, filed 28 Jul 2026.